NASDAQ: INMD
InMode Ltd.
Healthcare · Medical - Devices
Market Cap
$885.75M
52w High
$16.74
52w Low
$12.72
P/E
10.17
Volume
260.07K
Outstanding Shares
63.36M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 4.79% over the last year. Revenue declined 4.53% over the trailing twelve months. Operating margin moved from 28.05% to 21.31%. Free cash flow declined 25.67% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 21.31%. A decisive move in revenue — currently down 4.53% — would be the clearest signal to resolve the ambiguity.
Company profile
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally.
Valuation
Stock splits
Every 1 shares became 2
Profitability & growth
Analyst consensus
5
Buy
6
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 23, 2026
Q3 FY26 · EPS est $0.34 · Revenue est $92.65M
View